Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease.
Roche has announced the commercial availability of the cobas HCV Genotyping (GT) assay for the hepatitis C virus in countries...
Spinal muscular atrophy (SMA) is an autosomal recessive disease caused by mutation or deletion
The FDA has approved the Aptima HPV 16 18/45 Genotype Assay, from Hologic, for use on its Tigris instrument system....
The FDA has issued emergency use authorisation (EUA) of a diagnostic test for the novel coronavirus, reported to infect more...
The FDA has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer....
Roche announced the launch of a human papillomavirus (HPV) self sampling solution in countries accepting the CE mark.
BGI Genomics announced that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 in the Canadian market.